Cut-Off Value of Serum Uric Acid for Development of Gout Disease in Patients with Multiple Co-Morbidities
Objective: This study aimed to determine the association between hyperuricemia, comorbid diseases and risk of developing gout disease in a Turkish population in a long follow-up period. Methods: A total of 2000 Turkish adults were cross-sectionally analysed for serum urate levels in 2009 at the Pamu...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
PCO Convin S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0f529d927b3e42e8ac44f9d3a60251e0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:0f529d927b3e42e8ac44f9d3a60251e0 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:0f529d927b3e42e8ac44f9d3a60251e02021-11-08T08:28:47ZCut-Off Value of Serum Uric Acid for Development of Gout Disease in Patients with Multiple Co-Morbidities2529-198X10.31138/mjr.32.3.243https://doaj.org/article/0f529d927b3e42e8ac44f9d3a60251e02021-01-01T00:00:00Zhttp://www.mjrheum.org/assets/files/792/file332_1358.pdfhttps://doaj.org/toc/2529-198XObjective: This study aimed to determine the association between hyperuricemia, comorbid diseases and risk of developing gout disease in a Turkish population in a long follow-up period. Methods: A total of 2000 Turkish adults were cross-sectionally analysed for serum urate levels in 2009 at the Pamukkale University Faculty of Medicine. All patients on regular follow-up at our tertiary health center (n=1322) were included in this study. Demographic features (age and gender), comorbid clinical conditions, and medication use were noted. The risk of developing gout and the determinant factors were investigated. Multivariate logistic regression analysis was performed to analyse causative effects of factors while receiver operating characteristic (ROC) curve analysis was used to identify optimal cut-off values of uric acid level for predicting the development of gout. Results: Among 1322 patients, the mean age was 56.9 (SD:14.68) years. 57.3% (n=758) of the patients were female. The most common co-morbid disease was chronic kidney disease (581, 43%), followed by hypertension (522, 39.4%). Gout developed in 25 patients (1.8%). Gout development risk and presence of all the above comorbidities were significantly higher in patients with serum urate ≥7mg/dl compared with <7mg/dl. Male gender and not using urate lowering drugs were the main risk factors for developing gout disease. ROC analysis of serum uric acid levels identified a cut-off value of >7 (AUC: 0.776, sensitivity 86.96%, specificity 66.74%). Conclusion: There is still a dilemma concerning the culprit effects of both comorbidities and hyperuricemia on the risk of developing gout disease.Firdevs UlutaşAslı BozdemirNevzat Atalay ÇelikyürekCanan Albayrak YaşarVeli ÇobankaraPCO Convin S.A.articlehyperuricemiagoutco-morbid diseasecut-offDiseases of the musculoskeletal systemRC925-935ENMediterranean Journal of Rheumatology, Vol 32, Iss 3, Pp 243-248 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
hyperuricemia gout co-morbid disease cut-off Diseases of the musculoskeletal system RC925-935 |
spellingShingle |
hyperuricemia gout co-morbid disease cut-off Diseases of the musculoskeletal system RC925-935 Firdevs Ulutaş Aslı Bozdemir Nevzat Atalay Çelikyürek Canan Albayrak Yaşar Veli Çobankara Cut-Off Value of Serum Uric Acid for Development of Gout Disease in Patients with Multiple Co-Morbidities |
description |
Objective: This study aimed to determine the association between hyperuricemia, comorbid diseases and risk of developing gout disease in a Turkish population in a long follow-up period.
Methods: A total of 2000 Turkish adults were cross-sectionally analysed for serum urate levels in 2009 at the Pamukkale University Faculty of Medicine. All patients on regular follow-up at our tertiary health center (n=1322) were included in this study. Demographic features (age and gender), comorbid clinical conditions, and medication use were noted. The risk of developing gout and the determinant factors were investigated. Multivariate logistic regression analysis was performed to analyse causative effects of factors while receiver operating characteristic (ROC) curve analysis was used to identify optimal cut-off values of uric acid level for predicting the development of gout.
Results: Among 1322 patients, the mean age was 56.9 (SD:14.68) years. 57.3% (n=758) of the patients were female. The most common co-morbid disease was chronic kidney disease (581, 43%), followed by hypertension (522, 39.4%). Gout developed in 25 patients (1.8%). Gout development risk and presence of all the above comorbidities were significantly higher in patients with serum urate ≥7mg/dl compared with <7mg/dl. Male gender and not using urate lowering drugs were the main risk factors for developing gout disease. ROC analysis of serum uric acid levels identified a cut-off value of >7 (AUC: 0.776, sensitivity 86.96%, specificity 66.74%).
Conclusion: There is still a dilemma concerning the culprit effects of both comorbidities and hyperuricemia on the risk of developing gout disease. |
format |
article |
author |
Firdevs Ulutaş Aslı Bozdemir Nevzat Atalay Çelikyürek Canan Albayrak Yaşar Veli Çobankara |
author_facet |
Firdevs Ulutaş Aslı Bozdemir Nevzat Atalay Çelikyürek Canan Albayrak Yaşar Veli Çobankara |
author_sort |
Firdevs Ulutaş |
title |
Cut-Off Value of Serum Uric Acid for Development of Gout Disease in Patients with Multiple Co-Morbidities |
title_short |
Cut-Off Value of Serum Uric Acid for Development of Gout Disease in Patients with Multiple Co-Morbidities |
title_full |
Cut-Off Value of Serum Uric Acid for Development of Gout Disease in Patients with Multiple Co-Morbidities |
title_fullStr |
Cut-Off Value of Serum Uric Acid for Development of Gout Disease in Patients with Multiple Co-Morbidities |
title_full_unstemmed |
Cut-Off Value of Serum Uric Acid for Development of Gout Disease in Patients with Multiple Co-Morbidities |
title_sort |
cut-off value of serum uric acid for development of gout disease in patients with multiple co-morbidities |
publisher |
PCO Convin S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/0f529d927b3e42e8ac44f9d3a60251e0 |
work_keys_str_mv |
AT firdevsulutas cutoffvalueofserumuricacidfordevelopmentofgoutdiseaseinpatientswithmultiplecomorbidities AT aslıbozdemir cutoffvalueofserumuricacidfordevelopmentofgoutdiseaseinpatientswithmultiplecomorbidities AT nevzatatalaycelikyurek cutoffvalueofserumuricacidfordevelopmentofgoutdiseaseinpatientswithmultiplecomorbidities AT cananalbayrakyasar cutoffvalueofserumuricacidfordevelopmentofgoutdiseaseinpatientswithmultiplecomorbidities AT velicobankara cutoffvalueofserumuricacidfordevelopmentofgoutdiseaseinpatientswithmultiplecomorbidities |
_version_ |
1718442683197816832 |